Research summaries for everyoneNot medical advice
GHRP-2 research reference vial, Elevated Pharma

Research reference · Hormones

GHRP-2

GHRP-2 (pralmorelin) is a synthetic hexapeptide growth-hormone secretagogue. It has been used as a diagnostic test agent in Japan and studied in human endocrine research.

Published by Elevated Pharma ·

HormonesHuman research literature

Identity

What is GHRP-2?

A synthetic hexapeptide ghrelin-receptor agonist, also indexed as pralmorelin and KP-102.

Research context

What has GHRP-2 been studied for?

Human studies cover pharmacokinetics in children, GH release in critical illness and diagnostic testing of the pituitary.

Evidence boundary

What does the research not show?

Endocrine response data do not provide a general safety conclusion or establish an independently sourced material’s identity.

U.S. status · November 7, 2026

Is GHRP-2 FDA-approved?

Not FDA-approved. GHRP-2 was not on FDA’s 2026 compounding advisory agendas.

Key studies

The main GHRP-2 research

Selected from PubMed: human trials first, then reviews, then foundational laboratory work. Each finding applies to the material and setting studied.

Search all 223 PubMed records for GHRP-2 · Counts and selections checked November 7, 2026.

Reference identifiers

GHRP-2 identity data

Database identity describes the reference substance, not any specific material or lot.

Primary name
GHRP-2
Also indexed as
Growth hormone-releasing peptide 2 / Pralmorelin
Molecular formula
C45H55N9O6
Molecular mass
818 g/mol
PubChem CID
6918245

Official & primary sources

Regulatory and database records

Citation does not imply an Elevated Pharma partnership or endorsement.